Literature DB >> 34919671

Hypothalamic miR-1983 Targets Insulin Receptor β and the Insulin-mediated miR-1983 Increase Is Blocked by Metformin.

Jennifer A Chalmers1, Prasad S Dalvi1, Neruja Loganathan1, Emma K McIlwraith1, Leigh Wellhauser1, Anaies Nazarians-Armavil1, Judith A Eversley1, Haneesha Mohan1, Priska Stahel2, Satya Dash2,3, Michael B Wheeler1,2,3, Denise D Belsham1,2,4.   

Abstract

MicroRNAs (miRNAs) expressed in the hypothalamus are capable of regulating energy balance and peripheral metabolism by inhibiting translation of target messenger RNAs (mRNAs). Hypothalamic insulin resistance is known to precede that in the periphery, thus a critical unanswered question is whether central insulin resistance creates a specific hypothalamic miRNA signature that can be identified and targeted. Here we show that miR-1983, a unique miRNA, is upregulated in vitro in 2 insulin-resistant immortalized hypothalamic neuronal neuropeptide Y-expressing models, and in vivo in hyperinsulinemic mice, with a concomitant decrease of insulin receptor β subunit protein, a target of miR-1983. Importantly, we demonstrate that miR-1983 is detectable in human blood serum and that its levels significantly correlate with blood insulin and the homeostatic model assessment of insulin resistance. Levels of miR-1983 are normalized with metformin exposure in mouse hypothalamic neuronal cell culture. Our findings provide evidence for miR-1983 as a unique biomarker of cellular insulin resistance, and a potential therapeutic target for prevention of human metabolic disease.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NPY neuron; hyperinsulinemia; hypothalamus; insulin resistance; microRNA; obesity

Mesh:

Substances:

Year:  2022        PMID: 34919671      PMCID: PMC8682955          DOI: 10.1210/endocr/bqab241

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  60 in total

1.  MicroRNA expression is required for pancreatic islet cell genesis in the mouse.

Authors:  Francis C Lynn; Peter Skewes-Cox; Yasuhiro Kosaka; Michael T McManus; Brian D Harfe; Michael S German
Journal:  Diabetes       Date:  2007-09-05       Impact factor: 9.461

Review 2.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

3.  Consumption of a high-fat diet induces central insulin resistance independent of adiposity.

Authors:  Deborah J Clegg; Koro Gotoh; Christopher Kemp; Matthew D Wortman; Stephen C Benoit; Lynda M Brown; David D'Alessio; Patrick Tso; Randy J Seeley; Stephen C Woods
Journal:  Physiol Behav       Date:  2011-01-15

4.  Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b.

Authors:  Jan-Wilhelm Kornfeld; Catherina Baitzel; A Christine Könner; Hayley T Nicholls; Merly C Vogt; Karolin Herrmanns; Ludger Scheja; Cécile Haumaitre; Anna M Wolf; Uwe Knippschild; Jost Seibler; Silvia Cereghini; Joerg Heeren; Markus Stoffel; Jens C Brüning
Journal:  Nature       Date:  2013-02-07       Impact factor: 49.962

5.  Aldosterone regulates microRNAs in the cortical collecting duct to alter sodium transport.

Authors:  Robert S Edinger; Claudia Coronnello; Andrew J Bodnar; Mariana Labarca; Vivek Bhalla; William A LaFramboise; Panayiotis V Benos; Jacqueline Ho; John P Johnson; Michael B Butterworth
Journal:  J Am Soc Nephrol       Date:  2014-04-17       Impact factor: 10.121

6.  Weight-reduction through a low-fat diet causes differential expression of circulating microRNAs in obese C57BL/6 mice.

Authors:  Ching-Hua Hsieh; Cheng-Shyuan Rau; Shao-Chun Wu; Johnson Chia-Shen Yang; Yi-Chan Wu; Tsu-Hsiang Lu; Siou-Ling Tzeng; Chia-Jung Wu; Chia-Wei Lin
Journal:  BMC Genomics       Date:  2015-09-16       Impact factor: 3.969

7.  Adipose-derived circulating miRNAs regulate gene expression in other tissues.

Authors:  Thomas Thomou; Marcelo A Mori; Jonathan M Dreyfuss; Masahiro Konishi; Masaji Sakaguchi; Christian Wolfrum; Tata Nageswara Rao; Jonathon N Winnay; Ruben Garcia-Martin; Steven K Grinspoon; Phillip Gorden; C Ronald Kahn
Journal:  Nature       Date:  2017-02-15       Impact factor: 49.962

8.  Profiles of Circulating MiRNAs Following Metformin Treatment in Patients with Type 2 Diabetes.

Authors:  İbrahim Halil Demirsoy; Duygu Yolal Ertural; Şenay Balci; Ümit Çınkır; Kerem Sezer; Lülüfer Tamer; Nurcan Aras
Journal:  J Med Biochem       Date:  2018-12-01       Impact factor: 3.402

9.  Metformin shows anti-inflammatory effects in murine macrophages through Dicer/microribonucleic acid-34a-5p and microribonucleic acid-125b-5p.

Authors:  Xi Luo; Rong Hu; Ying Zheng; Shiping Liu; Zhiguang Zhou
Journal:  J Diabetes Investig       Date:  2019-06-25       Impact factor: 4.232

10.  Metformin inhibits food intake and neuropeptide Y gene expression in the hypothalamus.

Authors:  Yale Duan; Rui Zhang; Min Zhang; Lijuan Sun; Suzhen Dong; Gang Wang; Jun Zhang; Zheng Zhao
Journal:  Neural Regen Res       Date:  2013-09-05       Impact factor: 5.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.